Phase II/III Outsourcing Partner Selection Attributes

In Q1 & Q2 of 2022 ISR surveyed 132 sponsors worldwide who outsource Phase II/III studies and asked them to identify attributes that are important to them when selecting an outsourcing partner. The research revealed that respondents valued Operational excellence and Therapeutic expertise quite highly when choosing a provider for their Phase II/III studies. To learn more about outsourcers Phase II/III study needs, market dynamics, and their use of different service providers, Check out ISR’s Phase II/III Market Outlook report preview.